nach oben

Erschienen in:

04.07.2018 | Interventional

Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients

verfasst von: Kao-Lang Liu, Bo-Ching Lee, Jian-De Ye, Yu-Hsuan Chang, Chin-Chen Chang, Kuo-How Huang, Yuan-Ju Lee, Yeun-Chung Chang

Erschienen in: European Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this study was to compare single and tandem ureteral stenting in the management of malignant ureteral obstruction (MUO).

Methods

Our hospital’s institutional review board approved this prospective study. Between November 2014 and June 2017, single ureteral stenting was performed in 56 patients (94 renal units) and tandem ureteral stenting in 48 patients (63 renal units) for MUO. A comparative analysis of the technical success rate, patient survival, stent patency, and complications was performed.

Results

Similar demographic data were observed in patients receiving either single or tandem ureteral stenting. The technical success rate was 93.6% (88/94) for single ureteral stenting and 95.2% (60/63) for tandem ureteral stenting. There was no difference in overall survival between patients receiving single or tandem ureteral stenting (p = 0.41), but the duration of stent patency in tandem ureteral stenting was significantly longer (p = 0.022). The mean patency time was 176.7 ± 21.3 days for single ureteral stenting, and 214.7 ± 21.0 days for tandem ureteral stenting. The complications of ureteral stenting were urinary tract infection (n = 18), lower urinary tract symptoms (n = 5), haematuria (n = 3), and stent migration (n = 1).

Conclusions

Tandem ureteral stenting is a safe and feasible treatment for MUO, and had better efficacy compared to single ureteral stenting.

Key Points

• Ureteral stenting is an established treatment for the management of malignant ureteral obstruction (MUO)

• Prospective single-centre study showed that tandem ureteral stenting is a safe and feasible treatment for MUO

• Tandem ureteral stenting provides longer stent patency compared to single ureteral stenting in patient with MUO

Kouba E, Wallen EM, Pruthi RS (2008) Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. J Urol 180:444–450CrossRef

Wong LM, Cleeve LK, Milner AD, Pitman AG (2007) Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol 178:178–183 discussion 183CrossRef

Feng MI, Bellman GC, Shapiro CE (1999) Management of ureteral obstruction secondary to pelvic malignancies. J Endourol 13:521–524CrossRef

Sharer W, Grayhack JT, Graham J (1978) Palliative urinary diversion for malignant ureteral obstruction. J Urol 120:162–164CrossRef

Fiuk J, Bao Y, Calleary JG, Schwartz BF, Denstedt JD (2015) The use of internal stents in chronic ureteral obstruction. J Urol 193:1092–1100CrossRef

Chung SY, Stein RJ, Landsittel D et al (2004) 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 172:592–595CrossRef

Ganatra AM, Loughlin KR (2005) The management of malignant ureteral obstruction treated with ureteral stents. J Urol 174:2125–2128CrossRef

Rosevear HM, Kim SP, Wenzler DL, Faerber GJ, Roberts WW, Wolf JS Jr (2007) Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan. Urology 70:846–850CrossRef

Yossepowitch O, Lifshitz DA, Dekel Y et al (2001) Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol 166:1746–1749CrossRef

10.

Liu JS, Hrebinko RL (1998) The use of 2 ipsilateral ureteral stents for relief of ureteral obstruction from extrinsic compression. J Urol 159:179–181CrossRef

11.

Kilciler M, Erdemir F, Bedir S et al (2005) Using two ipsilateral double j ureteral stents for extrinsic ureteral obstruction due to colon carcinoma. Urol Int 75:319–321CrossRef

12.

Chen HC, Shen SH, Wang JH et al (2011) Parallel second stent placement for refractory ureteral stent malfunction in malignant ureteral obstruction. J Vasc Interv Radiol 22:1012–1016CrossRef

13.

Elsamra SE, Motato H, Moreira DM et al (2013) Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy. J Endourol 27:1297–1302CrossRef

14.

Varnavas M, Bolgeri M, Mukhtar S, Anson K (2016) The role of tandem double-J ureteral stents in the management of malignant ureteral obstruction. J Endourol 30:465–468CrossRef

15.

Ozyer U, Dirim A (2017) Tandem ureteral stents in the management of double-J stent dysfunction in gynecological malignancies. Diagn Interv Imaging 98:601–608CrossRef

16.

Cordeiro MD, Coelho RF, Chade DC et al (2016) A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients. BJU Int 117:266–271CrossRef

17.

Ishioka J, Kageyama Y, Inoue M, Higashi Y, Kihara K (2008) Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol 180:618–621 discussion 621CrossRef

18.

Bahu R, Chaftari AM, Hachem RY et al (2013) Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology. infection rate and risk factors. J Urol 189:130–135

19.

Kaskarelis IS, Papadaki MG, Malliaraki NE, Robotis ED, Malagari KS, Piperopoulos PN (2001) Complications of percutaneous nephrostomy, percutaneous insertion of ureteral endoprosthesis. and replacement procedures. Cardiovasc Intervent Radiol 24:224–228CrossRef

20.

Hyams ES, Shah O (2008) Malignant extrinsic ureteral obstruction: a survey of urologists and medical oncologists regarding treatment patterns and preferences. Urology 72:51–56CrossRef

21.

Monsky WL, Molloy C, Jin B et al (2013) Quality-of-life assessment after palliative interventions to manage malignant ureteral obstruction. Cardiovasc Intervent Radiol 36:1355–1363CrossRef

22.

Izumi K, Mizokami A, Maeda Y, Koh E, Namiki M (2011) Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol 185:556–561CrossRef

23.

Rosenberg BH, Bianco FJ Jr, Wood DP Jr, Triest JA (2005) Stent-change therapy in advanced malignancies with ureteral obstruction. J Endourol 19:63–67CrossRef

24.

Dyer RB, Chen MY, Zagoria RJ, Regan JD, Hood CG, Kavanagh PV (2002) Complications of ureteral stent placement. Radiographics 22:1005–1022CrossRef

25.

Rotariu P, Yohannes P, Alexianu M et al (2001) Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents. J Endourol 15:979–983CrossRef

26.

Fromer DL, Shabsigh A, Benson MC, Gupta M (2002) Simultaneous multiple double pigtail stents for malignant ureteral obstruction. Urology 59:594–596CrossRef

27.

Khoo CCK, Abboudi H, Cartwright R, El-Husseiny T, Dasgupta R (2018) Metallic ureteric stents in malignant ureteric obstruction: a systematic review. Urology. https://doi.org/10.1016/j.urology.2018.01.019

28.

Chow PM, Chiang IN, Chen CY et al (2015) Malignant ureteral obstruction: functional duration of metallic versus polymeric ureteral stents. PLoS One 10:e0135566CrossRef

29.

Kim JH, Song K, Jo MK, Park JW (2012) Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience. Korean J Urol 53:625–631CrossRef

30.

Chung KJ, Park BH, Park B et al (2013) Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa) in malignant ureteral obstructions. J Endourol 27:930–935CrossRef

31.

Chung HH, Kim MD, Won JY et al (2014) Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion. Cardiovasc Intervent Radiol 37:463–470CrossRef

32.

Klarskov P, Nordling J, Nielsen JB (2005) Experience with Memokath 051 ureteral stent. Scand J Urol Nephrol 39:169–172CrossRef

33.

Agrawal S, Brown CT, Bellamy EA, Kulkarni R (2009) The thermo-expandable metallic ureteric stent: an 11-year follow-up. BJU Int 103:372–376CrossRef

34.

Kim KS, Choi S, Choi YS et al (2014) Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions. J Laparoendosc Adv Surg Tech A 24:550–555CrossRef

35.

Moskovitz B, Halachmi S, Nativ O (2012) A new self-expanding, large-caliber ureteral stent: results of a multicenter experience. J Endourol 26:1523–1527CrossRef

36.

Elsamra SE, Leavitt DA, Motato HA et al (2015) Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents. Int J Urol 22:629–636CrossRef

37.

Chitale SV, Scott-Barrett S, Ho ET, Burgess NA (2002) The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 57:1118–1121CrossRef

38.

Song Y, Fei X, Song Y (2012) Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies. Int J Gynecol Cancer 22:697–702CrossRef

39.

Uthappa MC, Cowan NC (2005) Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction? Clin Radiol 60:608–612CrossRef

40.

Hackethorn JC, Boren SR, Dotter CT, Rosch J (1985) Antegrade internal ureteral stenting: a technical refinement. Radiology 156:827–828CrossRef

41.

Lu DS, Papanicolaou N, Girard M, Lee MJ, Yoder IC (1994) Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol 49:256–261CrossRef

42.

Sharma SD, Persad RA, Haq A et al (1996) A review of antegrade stenting in the management of the obstructed kidney. Br J Urol 78:511–515CrossRef

43.

Giannarini G, Keeley FX Jr, Valent F et al (2011) Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int 107:648–654CrossRef

44.

Hausegger KA, Portugaller HR (2006) Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications. Eur Radiol 16:2016–2030CrossRef

45.

Richter S, Ringel A, Shalev M, Nissenkorn I (2000) The indwelling ureteric stent: a 'friendly' procedure with unfriendly high morbidity. BJU Int 85:408–411CrossRef

46.

Radecka E, Magnusson A (2004) Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol 45:184–188CrossRef

47.

Hung SC, Chiang IN, Huang CY, Pu YS (2018) The effectiveness and durability of ureteral tumor stent, the national taiwan university hospital experience. Urol Sci 29:7–11

Titel: Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients
verfasst von: Kao-Lang Liu
Bo-Ching Lee
Jian-De Ye
Yu-Hsuan Chang
Chin-Chen Chang
Kuo-How Huang
Yuan-Ju Lee
Yeun-Chung Chang
Publikationsdatum: 04.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 2/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-018-5560-6

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients